BioNTech SE is 11.3x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($22.18 B vs $1.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADMA | BNTX |
|---|---|---|
| Market cap | $1.97 B | $22.18 B |
| US-listed rank | #2111 | #582 |
| Revenue (latest FY) | $510.17M | - |
| Net income (latest FY) | $146.93M | - |
| Net margin | 28.8% | - |
| P/E (trailing FY) | 13.4 | - |
| SEC filings | 988 | 548 |
BioNTech SE is 11.3x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($22.18 B vs $1.97 B).
Full pages: ADMA BIOLOGICS, INC. and BioNTech SE, or browse the full rankings.